| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.079 | 0.5 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |